Patent challenges to antibody and gene-therapy firms on the rise

Overview of attention for news story in Nature Biotechnology

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 317,694 followers.

RT @NatureBiotech: Patent challenges to antibody and gene-therapy firms on the rise https://t.co/AvJa3ivbda https://t.co/dQ4QVwiSC9

RT @NatureBiotech: Patent challenges to antibody and gene-therapy firms on the rise https://t.co/AvJa3ivbda https://t.co/dQ4QVwiSC9

RT @NatureBiotech: Patent challenges to antibody and gene-therapy firms on the rise https://t.co/AvJa3ivbda https://t.co/dQ4QVwiSC9

RT @NatureBiotech: Patent challenges to antibody and gene-therapy firms on the rise https://t.co/AvJa3ivbda https://t.co/dQ4QVwiSC9

RT @NatureBiotech: Patent challenges to antibody and gene-therapy firms on the rise https://t.co/AvJa3ivbda https://t.co/dQ4QVwiSC9

RT @NatureBiotech: Patent challenges to antibody and gene-therapy firms on the rise https://t.co/AvJa3ivbda https://t.co/dQ4QVwiSC9

RT @NatureBiotech: Patent challenges to antibody and gene-therapy firms on the rise https://t.co/AvJa3ivbda https://t.co/dQ4QVwiSC9

Patent challenges to antibody and gene-therapy firms on the rise https://t.co/AvJa3ivbda https://t.co/dQ4QVwiSC9